Insider Transactions in Q1 2025 at Anika Therapeutics, Inc. (ANIK)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 11
2025
|
Cheryl R Blanchard President, CEO, Director |
SELL
Payment of exercise price or tax liability
|
Direct |
12,675
-6.43%
|
$202,800
$16.79 P/Share
|
|
Mar 11
2025
|
Cheryl R Blanchard President, CEO, Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,060
+13.24%
|
-
|
|
Mar 11
2025
|
David Colleran EVP, General Counsel, Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
2,250
-4.93%
|
$36,000
$16.79 P/Share
|
|
Mar 11
2025
|
David Colleran EVP, General Counsel, Corp Sec |
BUY
Exercise of conversion of derivative security
|
Direct |
7,663
+14.37%
|
-
|
|
Mar 11
2025
|
Anne Nunes SVP, Chief Operations Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
752
-3.99%
|
$12,032
$16.79 P/Share
|
|
Mar 11
2025
|
Anne Nunes SVP, Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,561
+11.97%
|
-
|
|
Mar 10
2025
|
Cheryl R Blanchard President, CEO, Director |
SELL
Payment of exercise price or tax liability
|
Direct |
5,871
-3.4%
|
$93,936
$16.62 P/Share
|
|
Mar 10
2025
|
Cheryl R Blanchard President, CEO, Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,002
+10.37%
|
-
|
|
Mar 10
2025
|
David Colleran EVP, General Counsel, Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
1,604
-4.05%
|
$25,664
$16.62 P/Share
|
|
Mar 10
2025
|
David Colleran EVP, General Counsel, Corp Sec |
BUY
Exercise of conversion of derivative security
|
Direct |
5,465
+12.13%
|
-
|
|
Mar 10
2025
|
Anne Nunes SVP, Chief Operations Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
959
-5.56%
|
$15,344
$16.62 P/Share
|
|
Mar 10
2025
|
Anne Nunes SVP, Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,296
+16.05%
|
-
|